- Home
- OXM vs SLP Comparison
OXM vs SLP Comparison
Compare OXM & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXM
- SLP
- Stock Information
- Founded
- OXM 1942
- SLP 1996
- Country
- OXM United States
- SLP United States
- Employees
- OXM N/A
- SLP N/A
- Industry
- OXM Apparel
- SLP EDP Services
- Sector
- OXM Consumer Discretionary
- SLP Technology
- Exchange
- OXM Nasdaq
- SLP Nasdaq
- Market Cap
- OXM 672.2M
- SLP 675.9M
- IPO Year
- OXM N/A
- SLP 1997
- Fundamental
- Price
- OXM $41.17
- SLP $17.16
- Analyst Decision
- OXM Hold
- SLP Buy
- Analyst Count
- OXM 6
- SLP 7
- Target Price
- OXM $55.80
- SLP $40.40
- AVG Volume (30 Days)
- OXM 510.6K
- SLP 454.9K
- Earning Date
- OXM 06-11-2025
- SLP 07-02-2025
- Dividend Yield
- OXM 6.69%
- SLP 0.35%
- EPS Growth
- OXM 100.54
- SLP N/A
- EPS
- OXM 5.14
- SLP 0.36
- Revenue
- OXM $1,511,278,000.00
- SLP $78,564,000.00
- Revenue This Year
- OXM $0.49
- SLP $27.66
- Revenue Next Year
- OXM $1.90
- SLP $6.75
- P/E Ratio
- OXM $8.03
- SLP $47.57
- Revenue Growth
- OXM N/A
- SLP 21.49
- 52 Week Low
- OXM $38.74
- SLP $17.05
- 52 Week High
- OXM $108.51
- SLP $49.72
- Technical
- Relative Strength Index (RSI)
- OXM 30.89
- SLP 18.67
- Support Level
- OXM $40.46
- SLP $18.66
- Resistance Level
- OXM $43.00
- SLP $28.65
- Average True Range (ATR)
- OXM 2.58
- SLP 1.74
- MACD
- OXM -1.40
- SLP -1.05
- Stochastic Oscillator
- OXM 13.77
- SLP 3.78
About OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.